TY  - CONF

T1  - Dupilumab improves Eczema Area and Severity Index regional scores across all anatomical regions in children aged 6-11 years with severe atopic dermatitis (AD)

JO  - JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

PY  - 2021/01/01

AU  - Paller AS

AU  - Cork MJ

AU  - Marcoux D

AU  - Wollenberg A

AU  - Prescilla R

AU  - Chen Z

AU  - Rossi AB

AU  - Shumel B

ED  - 

VL  - 85

IS  - 3

SP  - AB136

EP  - AB136

Y2  - 2024/12/22

ER  -